Evidence map›Paper›PMID 29504010›Full record

ArticleSoft matter2018

From 2D to 3D patches on multifunctional particles: how microcontact printing creates a new dimension of functionality.

Marc Zimmermann, Daniela John, Dmitry Grigoriev, Nikolay Puretskiy, Alexander Böker

Abstract read
In one paragraph

Article in Soft matter, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marc ZimmermannFraunhofer Institute for Applied Polymer Research IAP, D-14476 Potsdam-Golm, Germany. marc.zimmemann@iap.fraunhofer.de alexander.boeker@iap.fraunhofer.de and Chair of Polymer Materials and Polymer Technologies, University Potsdam, D-14476 Potsdam-Golm, Germany.ORCID http://orcid.org/0000-0003-0977-7839
Daniela JohnFraunhofer Institute for Applied Polymer Research IAP, D-14476 Potsdam-Golm, Germany. marc.zimmemann@iap.fraunhofer.de alexander.boeker@iap.fraunhofer.de.
Dmitry GrigorievFraunhofer Institute for Applied Polymer Research IAP, D-14476 Potsdam-Golm, Germany. marc.zimmemann@iap.fraunhofer.de alexander.boeker@iap.fraunhofer.de.
Nikolay PuretskiyFraunhofer Institute for Applied Polymer Research IAP, D-14476 Potsdam-Golm, Germany. marc.zimmemann@iap.fraunhofer.de alexander.boeker@iap.fraunhofer.de.
Alexander BökerFraunhofer Institute for Applied Polymer Research IAP, D-14476 Potsdam-Golm, Germany. marc.zimmemann@iap.fraunhofer.de alexander.boeker@iap.fraunhofer.de and Chair of Polymer Materials and Polymer Technologies, University Potsdam, D-14476 Potsdam-Golm, Germany.ORCID http://orcid.org/0000-0002-5760-6631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A straightforward approach for the precise multifunctional surface modification of particles with three-dimensional patches using microcontact printing is presented. By comparison to previous works it was possible to not only control the diameter, but also to finely tune the thickness of the deposited layer, opening up the way for three-dimensional structures and orthogonal multifunctionality. The use of PEI as polymeric ink, PDMS stamps for microcontact printing on silica particles and the influence of different solvents during particle release on the creation of functional particles with three-dimensional patches are described. Finally, by introducing fluorescent properties by incorporation of quantum dots into patches and by particle self-assembly via avidin-biotin coupling, the versatility of this novel modification method is demonstrated.

Identifiers

PMID29504010
PMCPMC5870046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.